HEART TRANSPLANTATION - ADULT (HTX) -> HTX - Diagnostics/Patient Management Abstracts

630 - Giant Cell Myocarditis: Excellent Outcome after Heart Transplant Using Anti-Thymocyte Globulin

Presentation Number
630
Speakers
Session Name
POSTER SESSION 1 - POSTER SESSION: Heart Transplantation - Adult
Date
Wed, Apr 22, 2020
Time
06:00 PM - 07:15 PM
Authors

Previous ePresentation
629 - Absolute Lymphocyte Count as a Surrogate for Lymphocyte Phenotype Analysis of CD3 Count in Monitoring Thymoglobulin Response Post Heart Transplantation

Next ePresentations
632 - Outcomes of Heart Transplant in a Sensitized Latin American Population
633 - Has Short-Term Mechanical Circulatory Support an Impact on Post-Heart Transplant Vasoplegia?
638 - Heart Transplantation Outcomes in Multiorgan Transplants
641 - Post-Transplant Outcomes for Patients Based on Their Duration of Smoking Cessation at the Time of Heart Transplant (HT) Listing
647 - Impact of Current Donor Scores Calculation on Heart Transplantation Outcomes
648 - Does Brain Death Related to Underlying Donor Disease Correlate with Adverse Outcomes after Heart Transplant?
649 - The Effect of the New UNOS Heart Allocation on Donation Service Area and Heart Transplant Program Logistics: The Mid America Experience
651 - Same Game New Rules: What is the Impact of the 2018 UNOS Heart Allocation Change?
652 - Combined Heart-Kidney Transplantation: Vasoplegia is Associated with Poorer Post-Kidney Transplant Outcomes
655 - Assessment of Aortic Root Size in Donor Heart Predicts Short and Long Term Recipient Outcomes after Orthotopic Heart Transplantation